Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCA Healthcare, Inc.HCA · Entity 2929 | SVP; Chief Development Officer | August 05, 2024 | August 07, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCA Healthcare, Inc.
Report date August 05, 2024 · Filed August 07, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-08-05 transaction · row 1
1 source rowRow 1 · 2024-08-05 · Gift · Disposed 13,367 · Balance 0 |
| Common StockSEC Table I · non-derivative | IndirectBy 2023 Trust | 18,526 |
Reported balance
After 2024-08-05 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-08-05 · Gift · Acquired 13,367 · Balance 18,526 |
| Common StockSEC Table I · non-derivative | IndirectBy 2023 Spouse Trust | 29,771 |
Reported balance
Holding disclosure · report date 2024-08-05 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 29,771 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust (Reporting Person, Trustee) | 8,000 |
Reported balance
Holding disclosure · report date 2024-08-05 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 8,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 05, 2024 Filed Aug 7, 2024 19:25 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 13,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-093147 · ownership.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By 2023 Trust Disclosed balance after: 18,526 Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 19:25 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 13,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-093147 · ownership.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 15, 2024 Filed May 17, 2024 17:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 19,000 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-24-005662 · doc4.xml · derivative · entry 6 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,000 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016. Read SEC document |
| May 15, 2024 Filed May 17, 2024 17:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 9,908 | $326.96 | $3,239,519.68 |
DisclosureSEC source: 0001209191-24-005662 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,367 Read SEC document |
| May 15, 2024 Filed May 17, 2024 17:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 19,000 | $68.96 | $1,310,240.00 |
DisclosureSEC source: 0001209191-24-005662 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 19:34 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 2,005 | $308.55 | $618,642.75 |
DisclosureSEC source: 0001209191-24-003753 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,275 Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 19:34 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 6,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-003753 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,280 F1 · kind: On February 3, 2021, the reporting person was granted 3,140 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:50 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 4,402 | $0.00 Strike: $304.90 | $0.00 |
DisclosureSEC source: 0001209191-24-002731 · doc4.xml · derivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,402 Underlying: Common Stock · 4,402 shares Expires 2034-01-31 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025. Read SEC document |
| November 14, 2023 Filed Nov 14, 2023 18:36 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 5,159 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-055226 · doc4.xml · nonDerivative · entry 6 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By 2023 Trust Disclosed balance after: 5,159 Read SEC document |
| November 14, 2023 Filed Nov 14, 2023 18:36 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 5,159 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-055226 · doc4.xml · nonDerivative · entry 5 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 14, 2023 Filed Nov 14, 2023 18:36 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 29,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-055226 · doc4.xml · nonDerivative · entry 4 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By 2023 Spouse Trust Disclosed balance after: 29,771 Read SEC document |
| November 14, 2023 Filed Nov 14, 2023 18:36 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 29,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-055226 · doc4.xml · nonDerivative · entry 3 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 29,771 Read SEC document |
| November 10, 2023 Filed Nov 14, 2023 18:36 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 29,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-055226 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 29,771 Read SEC document |
| November 10, 2023 Filed Nov 14, 2023 18:36 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 29,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-055226 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust (Reporting Person and Spouse, Trustees) Disclosed balance after: 0 Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 20:09 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 2,441 | $262.84 | $641,592.44 |
DisclosureSEC source: 0001209191-23-012008 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,159 Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 20:09 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 7,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012008 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,600 F1 · kind: On January 29, 2020, the reporting person was granted 3,800 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 20:05 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 6,315 | $0.00 Strike: $253.30 | $0.00 |
DisclosureSEC source: 0001209191-23-006042 · doc4.xml · derivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,315 Underlying: Common Stock · 6,315 shares Expires 2033-01-30 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 18:30 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 12,946 | $223.18 | $2,889,303.82 |
DisclosureSEC source: 0001209191-22-055125 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.00 to $223.71, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 18:51 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 27,500 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-22-054745 · doc4.xml · derivative · entry 8 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,500 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 18:51 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 14,554 | $214.40 | $3,120,377.60 |
DisclosureSEC source: 0001209191-22-054745 · doc4.xml · nonDerivative · entry 6 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,946 Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 18:51 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 27,500 | $47.97 | $1,319,175.00 |
DisclosureSEC source: 0001209191-22-054745 · doc4.xml · nonDerivative · entry 5 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 18:51 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 3,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-054745 · doc4.xml · nonDerivative · entry 4 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust (Reporting Person and Spouse, Trustees) Disclosed balance after: 29,771 Read SEC document |
| August 10, 2022 Filed Oct 27, 2022 18:51 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 17,051 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-054745 · doc4.xml · nonDerivative · entry 3 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust (Reporting Person and Spouse, Trustees) Disclosed balance after: 33,371 Read SEC document |
| August 10, 2022 Filed Oct 27, 2022 18:51 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 17,051 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-054745 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 04, 2022 Filed Oct 27, 2022 18:51 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-054745 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust (Reporting Person and Spouse, Trustees) Disclosed balance after: 16,320 Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 18:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 11,522 | $269.00 | $3,099,418.00 |
DisclosureSEC source: 0001209191-22-018943 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,051 F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 3,046 | $244.10 | $743,528.60 |
DisclosureSEC source: 0001209191-22-012420 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,573 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 7,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012420 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,619 F1 · kind: On January 30, 2019, the reporting person was granted 3,870 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 19:35 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 6,930 | $0.00 Strike: $236.61 | $0.00 |
DisclosureSEC source: 0001209191-22-006086 · doc4.xml · derivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,930 Underlying: Common Stock · 6,930 shares Expires 2032-01-28 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 18:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 23,375 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-22-002235 · doc4.xml · derivative · entry 6 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,375 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 18:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 11,853 | $258.97 | $3,069,571.41 |
DisclosureSEC source: 0001209191-22-002235 · doc4.xml · nonDerivative · entry 3 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,879 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 18:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 23,375 | $47.97 | $1,121,298.75 |
DisclosureSEC source: 0001209191-22-002235 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 18:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 22,198 | $259.23 | $5,754,389.76 |
DisclosureSEC source: 0001209191-22-002235 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,357 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.00 to $259.79, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 29, 2021 Filed Jan 3, 2022 18:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 42,750 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-22-000339 · doc4.xml · derivative · entry 5 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,750 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| December 29, 2021 Filed Jan 3, 2022 18:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 20,552 | $258.49 | $5,312,486.48 |
DisclosureSEC source: 0001209191-22-000339 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,555 F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 29, 2021 Filed Jan 3, 2022 18:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 42,750 | $37.18 | $1,589,445.00 |
DisclosureSEC source: 0001209191-22-000339 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:46 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 3,160 | $174.61 | $551,767.60 |
DisclosureSEC source: 0001209191-21-013008 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,357 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:46 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 10,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013008 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,517 F1 · kind: On January 31, 2018, the reporting person was granted 6,230 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:31 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 10,460 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008353 · doc4.xml · derivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,460 Underlying: Common Stock · 10,460 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 3,066 | $150.08 | $460,145.28 |
DisclosureSEC source: 0001209191-20-011771 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,370 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 7,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011771 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,436 F1 · kind: On February 1, 2017, the reporting person was granted 6,610 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2017-2019. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2017-2019 earnings per share, the number of performance share units that vested equaled 117.86% of the units granted. Read SEC document |
| February 04, 2020 Filed Feb 6, 2020 18:43 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 21,309 | $145.00 | $3,089,805.00 |
DisclosureSEC source: 0001209191-20-007287 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 646 F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:46 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 13,800 | $0.00 Strike: $145.24 | $0.00 |
DisclosureSEC source: 0001209191-20-005893 · doc4.xml · derivative · entry 7 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,800 Underlying: Common Stock · 13,800 shares Expires 2030-01-29 F4 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:46 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 45,000 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-20-005893 · doc4.xml · derivative · entry 6 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:46 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 23,691 | $145.24 | $3,440,880.84 |
DisclosureSEC source: 0001209191-20-005893 · doc4.xml · nonDerivative · entry 3 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,955 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:46 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 45,000 | $37.18 | $1,673,100.00 |
DisclosureSEC source: 0001209191-20-005893 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 19:46 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 31,063 | $145.30 | $4,513,488.07 |
DisclosureSEC source: 0001209191-20-005893 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 646 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.66 to $145.96, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:03 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 60,654 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-19-061980 · doc4.xml · derivative · entry 6 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,654 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:03 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 29,591 | $147.53 | $4,365,560.23 |
DisclosureSEC source: 0001209191-19-061980 · doc4.xml · nonDerivative · entry 4 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,709 F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 17:03 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 60,654 | $22.95 | $1,392,009.30 |
DisclosureSEC source: 0001209191-19-061980 · doc4.xml · nonDerivative · entry 3 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.